Nobivac® Canine 1-Cv - Merck Animal Health USA

Canine 1-Cv

Proven combination vaccine that offers broad protection for dogs against common viral strains.

Product Description

CANINE CORONAVIRUS VACCINE

Nobivac® Canine 1-Cv is a killed virus vaccine shown to be effective against Canine coronavirus.

The virus has been inactivated and combined with an adjuvant designed to enhance the immune response
Shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine coronavirus.

Overview

Administration

Alternate

Resources

Indications:

Recommended for use in healthy dogs 6 weeks of age or older.

ADMINISTRATION AND DOSAGE

Inject initial 1 mL dose subcutaneously or intramuscularly
The initial dose may be given at 6 weeks of age
A second, required dose is given 2-4 weeks later
Contact your veterinarian or manufacturer for more information on revaccination frequency.
Use entire contents immediately
Available in a 25 x 1 mL dose presentation

ALSO AVAILABLE IN OTHER FORMULATIONS

Professional Resources and Educational Materials

Keep your clinic and staff informed and aware of diseases and outbreaks.

View More Nobivac Resources

EBook

Quick Guide to Lepto

A handy guide to protect dogs and prevent the spread of leptospirosis.

Digital Assets

Nobivac® Social Media Kits

SOP

AAHA Canine Vaccination Guidelines

In-depth information about canine vaccinations and veterinary best practices.

References

View All Nobivac References